Ruxolitinib Cream Demonstrated Rapid Reductions in Itch and Atopic Dermatitis Signs That Correlated With Biomarkers. Bissonnette R, Saint-Cyr Proulx E, Correa da Rosa J, Estrada Y, et al. J Invest Dermatol 2025 Nov 18:S0022-202X(25)03550.

Read + Share

Amedeo Smart

Independent Medical Education

Bissonnette R, Saint-Cyr Proulx E, Correa da Rosa J, Estrada Y, et al. Ruxolitinib Cream Demonstrated Rapid Reductions in Itch and Atopic Dermatitis Signs That Correlated With Biomarkers. J Invest Dermatol 2025 Nov 18:S0022-202X(25)03550.
PMID: 41265829